S11E10: For a clinicians perspective we talk with Dr. Kevin Yuen about Crinetics' new acromegaly drug Palsonify™.
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
S11E10: For a clinicians perspective we talk with Dr. Kevin Yuen about Crinetics' new acromegaly drug Palsonify™.
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In today's podcast, Dr. Kevin Yuen, a world-renowned neuroendocrinologist, frequent PWN contributor, and medical director of the Barrow Neurological Institute, discusses Crinetics' new acromegaly drug Paltusotine (Palsonify™). The drug was recently approved by the Food and Drug Administration. Dr. Yuen explains how this new medication works and provides an excellent clinical perspective on his views to evaluating new therapies. Read Dr. Kevin Yuen's PWN articles here.
Pas encore de commentaire